Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
N4 Pharma ( (GB:N4P) ) has issued an update.
N4 Pharma plc announced that all resolutions were passed at its annual general meeting, including the re-election and election of directors and the appointment of a new auditor. This successful AGM reflects strong shareholder support and positions the company to continue its development efforts in the biotech industry.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to enhance advanced therapies for cancer and other diseases.
Average Trading Volume: 1,691,883
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.